All News

Clinical Trials

Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
13 September 2023
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
Following a show-stopping and emotional
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
6 September 2023
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
Beam Therapeutics Announced First Patient
Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
FDA Grants Clearance of IND For LEXEO Therapeutics’ AAV-Based Gene Therapy
2 August 2023
FDA Grants Clearance of IND For LEXEO Therapeutics’ AAV-Based Gene Therapy
LEXEO Therapeutics, LEXEO, has announced
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Topical Gene Therapy Repairs Vision in Teen
26 July 2023
Topical Gene Therapy Repairs Vision in Teen
In a first-of-its-kind gene therapy,
Celebrating a Lifetime of Life-Changing Achievements
21 July 2023
Celebrating a Lifetime of Life-Changing Achievements
As entries for the 2024
The Next Wave: Cell and Gene Therapy’s Commercial Shift
20 July 2023
The Next Wave: Cell and Gene Therapy’s Commercial Shift
This full session from Advanced
Iovance Biotherapeutics Announces Positive Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
12 July 2023
Iovance Biotherapeutics Announces Positive Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
Iovance announced its positive regulatory
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map